<DOC>
	<DOC>NCT02129179</DOC>
	<brief_summary>This study aims to assess the effect of glucagon-like peptide-1 on cardiac output and transpulmonary gradient in patients undergoing right heart catheterisation for clinical reasons.</brief_summary>
	<brief_title>The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age over 18 Able to give informed consent On the waiting list for heart transplant Left Ventricular Dysfunction awaiting catheterisation Nicorandil, glibenclamide, Dipeptidyl Peptidase4 inhibitor, GlucagonLike Peptide1 receptor agonist or insulin Women of child bearing age and breast feeding women Cardiac pacemaker or other implanted metallic device Unable to give informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>